Effect of methylprednisolone in patients with Guillain-Barré syndrome [2] (multiple letters)

Lancet

Volumn 363, Issue 9416, 2004, Pages 1236-1237

  Susuki, Keiichiro ^a   Yuki, Nobuhiro ^a   Rossi, Gabriele ^b   Locatelli, Franco ^b   Van Doorn, P A ^c   Van Koningsveld, R ^c   Schmitz, P I M ^c  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FC RECEPTOR; GANGLIOSIDE GM1; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; RITUXIMAB;

CLINICAL TRIAL; DEMYELINATING DISEASE; DISEASE SEVERITY; GUILLAIN BARRE SYNDROME; HUMAN; LETTER; MYELIN SHEATH; NERVE FIBER; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 1842635490     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(04)15962-x     Document Type: Letter

References (0)